Concepedia

Publication | Open Access

Phase I study of AMG 211/MEDI-565 administered as continuous intravenous infusion (cIV) for relapsed/refractory gastrointestinal (GI) adenocarcinoma

26

Citations

0

References

2018

Year

No additional data available for this publication yet. Check back later!